EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...

Tea may offer powerful health benefits, but how it is prepared and consumed matters. Tea has a long history as both a ...

Time-restricted eating has been widely promoted as a simple way to boost metabolic health, but new research paints a more ...

A new study from the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) and Charité -- Universitätsmedizin Berlin challenges a widely held ...

Did you miss the most popular gastroenterology stories this year? Medscape Medical News tracked the news most popular with ...

Overall, the study concludes that vibrational forces generated by AcceleDent do not induce thermal changes in intraoral ...

This important study reports three experiments examining how the subjective experience of task regularities influences perceptual decision-making. Although the evidence linking subjective ratings to ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...

The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal ...

The CLL17 trial showed noninferiority of fixed-duration regimens compared to continuous BTK inhibitor therapy, highlighting ...